Summary
BeOne Medicines Ltd. (ONC) filed an 8-K on June 30, 2021, to update its Listing Application with historical financial information for the years ended December 31, 2018, 2019, and 2020. This financial data was prepared in accordance with China Accounting Standards for Business Enterprises (PRC GAAP), which differ from U.S. GAAP. The filing includes additional details on gross profit margin ratios by product. A summary of the key differences between PRC GAAP and U.S. GAAP, along with U.S. GAAP-adjusted financial information, is provided as an exhibit (Exhibit 99.1). This report also includes forward-looking statements regarding a proposed issuance of RMB Shares, subject to market conditions and regulatory approvals. Investors are cautioned that this proposed issuance may not materialize and should exercise caution when dealing in the company's securities. Further updates will be provided as developments occur.
Key Highlights
- 1Company updated its Listing Application with historical financial data for 2018-2020 prepared under PRC GAAP.
- 2Key differences between PRC GAAP and U.S. GAAP, and U.S. GAAP-adjusted financial information are provided in Exhibit 99.1.
- 3The filing includes product-specific gross profit margin ratio information for the reporting period.
- 4The Listing Application is available in Chinese on the Shanghai Stock Exchange website.
- 5Company disclosed forward-looking statements regarding a proposed issuance of RMB Shares.
- 6The proposed RMB Share issuance is contingent on market conditions and regulatory approvals.
- 7Investors are advised to exercise caution regarding the proposed RMB Share issuance due to uncertainty of its completion.